Dr. Richard C Frank is a full time medical oncology/hematology practice and serves as Director of Cancer Research for the Western CT Health Network, which runs investigator initiated, and phase I-III cooperative group and pharmaceutical trials. He is also a Clinical Assistant Professor of Medicine at Weill Cornell Medical College, New York, USA. Previously Dr. Frank was an attending physician at Memorial Sloan Kettering Cancer Center, where he had an NIH grant to investigate the role of transcription factors in AML. Dr. Frank was recognized as a Top Doc in the Newyork metro area by Castle Connolly and he is the author of the book "Fighting Cancer with Knowledge and Hope" (Yale Press 2013), which uniquely explains to patients what cancer is and why oncologists choose the therapies we do. He has maintained patient-oriented blogs on cancer for WebMD, Yale Press, CURE and other online journals. Dr. Frank's research interests in pancreatic cancer include 1) translational work investigating the role of non-coding RNA and ct DNA as diagnostic and prognostic markers, 2) novel therapeutics for advanced disease and 3) development of a screening program for high risk individuals.